Trendlines and shareholder-linked firms back ProArc in $390K SAFE deal
What's the deal? Trendlines GroupDealroom has a profile for this one. Try Dealroom → and LH Related CompaniesDealroom has a profile for this one. Try Dealroom → have jointly invested up to $390,000 in ProArc Medical, a portfolio company focused on medical innovation.
Each party is putting in up to $195,000 through a Simple Agreement for Future Equity (SAFE), a convertible instrument that swaps capital now for shares in a future round.
LH Related Companies are entities tied to Librae HoldingsDealroom has a profile for this one. Try Dealroom → Limited, Trendlines' controlling shareholder, ultimately linked to a trust benefiting Vincent Tchenguiz.
Why now? The fresh capital gives ProArc runway for research, development, and clinical trials — the milestones that move a medical startup closer to an exit.
Trendlines frames the co-investment as a way to sharpen ProArc's competitiveness and boost its odds of a value-creating exit.
What could go wrong? Deals involving a controlling shareholder invite scrutiny over conflicts of interest.
Trendlines says neither LH Related Companies nor Tchenguiz influenced the terms, which it calls normal commercial terms and not prejudicial to minority shareholders. Its audit committee, board, and ProArc's board all approved the transaction.
Under Singapore Exchange Catalist Rules and Israeli Companies Law, LH counts as a controlling shareholder, triggering interested-party review.
The company expects no material effect on consolidated earnings per share or net tangible assets for the year ending December 31, 2026.
The signal: ProArc Medical is an early-stage company developing a minimally invasive solution for benign prostatic hyperplasia, a field where clinical trial funding is the critical bottleneck. For an investment fund like Trendlines, topping up a portfolio company alongside its own controlling shareholder is as much about signalling conviction to outside backers as it is about the modest $390,000 cheque itself.
Read more: minichart.com.sg
Image credit: Dr. Eduardo García Cruz
